Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06213883 · ClinicalTrials.gov registry record · NA
Response to Acute Exercise in Eating Disorders
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
NCT06213883: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT06213883 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 74 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06213883, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
Study Summary
Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome. This study will develop tasks to characterize cognitive, affective, and biological response to exercise among adolescent and young adult females with EDs and determine whether acute exercise response associates with free-living activity and DEx. This R21 project will provide foundational data to guide research and development of treatments that are more precisely targeted to the symptom of driven exercise and to ultimately improve clinical outcomes associated with EDs.
Primary Outcome
Response to body image was measured using the BISS which is a 6-item scale that asks participants to report on their momentary body satisfaction on a 9-point Likert scale (1-9, higher scores, higher satisfaction). Each item begins with the sentence "Right now, I feel" \[for instance: "Right now, I feel (Extremely dissatisfied to Extremely satisfied)"\]. Participants are asked to rate their momentary body satisfaction every five minutes during each of 4 conditions: Prescribed Exercise (Reward Tas
Interventions
- OTHER Biobehavioral Response to in-lab exposure to physical activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2023-11-02 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
What the finished NCT06213883 record still lists
NCT06213883 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Biobehavioral Response to in-lab exposure to physical activity is the first listed.
NCT06213883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06213883 about?
NCT06213883 is a clinical study titled "Response to Acute Exercise in Eating Disorders". Individuals with eating disorders (ED) represent a high-priority clinical population, with among the highest mortality rates of any psychiatric disorder, and driven exercise (DEx) is a symptom evidenced in up to 80% of those with EDs that increases impairment and negatively impacts treatment outcome...
What is the current status of trial NCT06213883?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2023-11-02. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT06213883?
The interventions under investigation include: Biobehavioral Response to in-lab exposure to physical activity (OTHER).
Who is sponsoring clinical trial NCT06213883?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06213883's enrollment target sits among peer trials
74 1082nd of 2000 higher than 912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422731 · 74 participants · Early Phase 1
Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy
- NCT03804853 · 74 participants · NA
Rehabilitation Following Reverse Total Shoulder Arthroplasty
- NCT04065776 · 74 participants · NA
Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma
- NCT04771156 · 74 participants · Phase 4
Ketorolac in Palatoplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI